Method for treating secondary pulmonary hypertension

#The present disclosure relates generally to the field of pulmonary artery denervation in the treatment of secondary pulmonary hypertension.

#Pulmonary hypertension (PH) is an increase in blood pressure in the pulmonary artery, pulmonary vein, or pulmonary capillaries, together known as the lung vasculature.

#It is a disease phenomenon of multifactorial etiology with high mortality. The disease causes increased work for the right side of the heart and eventually hypertrophy and dysfunction, often in both the right and left side of the heart. Despite improvements in therapy, the prognosis of pulmonary hypertension is poor, with median survival being around 5 years.

#Some embodiments of the disclosure are described herein with reference to the accompanying figures. The description, together with the figures, makes apparent to a person having ordinary skill in the art how some embodiments of the disclosure may be practiced. The figures are for the purpose of illustrative purposes only.

#FIG. 1 is an illustrative flowchart of a method for ameliorating secondary pulmonary hypertension, according to some embodiments;

#FIG. 2 is an illustrative flowchart of a method for ameliorating secondary pulmonary hypertension, according to some embodiments;

#In the following description, various aspects of the disclosure will be described. For the purpose of explanation, specific configurations and details are set forth in order to provide a thorough understanding of the different aspects of the disclosure. However, it will also be apparent to one skilled in the art that the disclosure may be practiced without specific details being presented herein. Furthermore, well-known features may be omitted or simplified in order not to obscure the disclosure.

#The present disclosure relates generally to the field of pulmonary artery denervation in the treatment of secondary pulmonary hypertension.

#According to some embodiments, there is provided a method for ameliorating secondary pulmonary hypertension. According to some embodiments, the method includes positioning a pulmonary artery manipulation device in proximity to a target blood vessel within the pulmonary vasculature of a patient suffering from secondary pulmonary hypertension.